Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Voglibose> ?p ?o. }
Showing items 1 to 63 of
63
with 100 items per page.
- Voglibose abstract "Voglibose (INN and USAN, trade name Voglib, marketed by Mascot Health Series) is an alpha-glucosidase inhibitor used for lowering post-prandial blood glucose levels in people with diabetes mellitus. Voglibose delays the absorption of glucose thereby reduces the risk of macrovascular complications. Voglibose is a research product of Takeda Pharma, a Japan-based company.Postprandial hyperglycemia (PPHG) is primarily due to first phase insulin secretion. Alpha glucosidase inhibitors delay glucose absorption at the intestine level and thereby prevent sudden surge of glucose after a meal.There are three drugs which belong to this class, acarbose, miglitol and voglibose, of which voglibose is the newest. Voglibose scores over both acarbose and miglitol in terms of side effect profile. But acarbose has an edge over voglibose in terms of efficacy (FPG, PPHG, HBA1c).There are several trials supporting the use of voglibose in the management of PPHG. Also, it has been established that it is PPHG, not FPG, which is the marker of cardiovascular disorders associated with diabetes. So, controlling PPHG is imperative and voglibose is indicated for the management of PPHG.".
- Voglibose atcPrefix "A10".
- Voglibose atcSuffix "BF03".
- Voglibose casNumber "83480-29-9".
- Voglibose drugbank "DB04878".
- Voglibose fdaUniiCode "S77P977AG8".
- Voglibose iupacName "(1S,2S,3R,4S,5S)-5-(1,3-dihydroxypropan-2-ylamino)-1-(hydroxymethyl)cyclohexane-1,2,3,4-tetraol".
- Voglibose pubchem "444020".
- Voglibose thumbnail Voglibose_structure.svg?width=300.
- Voglibose wikiPageExternalLink medicalnews.php?newsid=36827.
- Voglibose wikiPageID "8821670".
- Voglibose wikiPageRevisionID "592763053".
- Voglibose atcPrefix "A10".
- Voglibose atcSuffix "BF03".
- Voglibose c "10".
- Voglibose casNumber "83480".
- Voglibose chembl "476960".
- Voglibose chemspiderid "392046".
- Voglibose drugbank "DB04878".
- Voglibose h "21".
- Voglibose hasPhotoCollection Voglibose.
- Voglibose inchi "1".
- Voglibose inchikey "FZNCGRZWXLXZSZ-CIQUZCHMBI".
- Voglibose iupacName "-5".
- Voglibose kegg "D01665".
- Voglibose molecularWeight "267.28".
- Voglibose n "1".
- Voglibose o "7".
- Voglibose pubchem "444020".
- Voglibose smiles "OC[C@@]1C[C@H][C@H][C@@H][C@@H]1O".
- Voglibose stdinchi "1".
- Voglibose stdinchikey "FZNCGRZWXLXZSZ-CIQUZCHMSA-N".
- Voglibose unii "S77P977AG8".
- Voglibose verifiedrevid "470631324".
- Voglibose subject Category:Alpha-glucosidase_inhibitors.
- Voglibose subject Category:Amino_sugars.
- Voglibose type Alpha-glucosidaseInhibitors.
- Voglibose type AminoSugars.
- Voglibose type Flavorer107809368.
- Voglibose type Food100021265.
- Voglibose type Foodstuff107566340.
- Voglibose type Ingredient107809096.
- Voglibose type Inhibitor114724436.
- Voglibose type Matter100020827.
- Voglibose type PhysicalEntity100001930.
- Voglibose type Substance100020090.
- Voglibose type Sugar107859284.
- Voglibose type Sweetening107858595.
- Voglibose type Drug.
- Voglibose type DrugProduct.
- Voglibose type FunctionalSubstance.
- Voglibose comment "Voglibose (INN and USAN, trade name Voglib, marketed by Mascot Health Series) is an alpha-glucosidase inhibitor used for lowering post-prandial blood glucose levels in people with diabetes mellitus. Voglibose delays the absorption of glucose thereby reduces the risk of macrovascular complications. Voglibose is a research product of Takeda Pharma, a Japan-based company.Postprandial hyperglycemia (PPHG) is primarily due to first phase insulin secretion.".
- Voglibose label "Voglibose".
- Voglibose label "Voglibose".
- Voglibose sameAs Voglibose.
- Voglibose sameAs m.027kz9f.
- Voglibose sameAs Q7939403.
- Voglibose sameAs Q7939403.
- Voglibose sameAs DB04878.
- Voglibose sameAs Voglibose.
- Voglibose wasDerivedFrom Voglibose?oldid=592763053.
- Voglibose depiction Voglibose_structure.svg.
- Voglibose isPrimaryTopicOf Voglibose.
